Medicis Pharmaceutical Financial Statements
Medicis Pharmaceutical Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Medicis Pharmaceutical Income Statement
| 2008 | 2007 | 2006+ | |
|---|---|---|---|
| Revenue ($ mil.) | 517.8 | 464.7 | 349.2 |
| Gross Profit ($ mil.) | 479.0 | 413.7 | 307.5 |
| Operating Income ($ mil.) | 49.1 | 136.1 | (106.0) |
| Total Net Income ($ mil.) | 10.3 | 75.1 | (75.8) |
| Diluted EPS (Net Income) | 0.18 | 1.14 | (1.39) |
- + Fiscal Year-End Change
Medicis Pharmaceutical Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 151.8 | 141.2 | 141.2 |
| Gross Profit ($ mil.) | 138.3 | 128.2 | 128.2 |
| Operating Income ($ mil.) | -- | 40.9 | 40.9 |
| Total Net Income ($ mil.) | 21.1 | 15.6 | 15.6 |
| Diluted EPS (Net Income) | 0.33 | 0.25 | 0.25 |
Medicis Pharmaceutical Stock Quote & Chart
11/06/09 16:03:15 EST •
NYSE •
22.70
•
 -0.1900
•
-0.8301 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Medicis Pharmaceutical Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.52 | 7.49 | 7.00 |
| Price/Earnings Ratio | (169.49) | 92.59 | 25.45 |
| Price/Book Ratio | 2.17 | 3.46 | 6.74 |
| Price/Cash Flow Ratio | 25.58 | 41.15 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Medicis Pharmaceutical Financial Ratios
Medicis Pharmaceutical Competitive Intelligence
| Allergan | Galderma Laboratories | Johnson & Johnson | |
|---|---|---|---|
| Annual Sales ($ mil.) | 4,403.4 | 0.0 | 63,747.0 |
| Employees | 8,740 | 499 | 118,700 |
| Market Cap ($ mil.) | 18,192.4 | -- | 165,490.8 |
Competitive Landscape
